The Texas Interprofessional Pharmacogenomics (IPGx)

Recruiting Observational Study
Adverse Drug Reaction
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
45 and older
Sex
Any
Study type
Observational
Participants needed
50 (estimated)
Sponsor
Texas A&M University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The investigator's primary aim is to evaluate polypharmacy-associated adverse drug reactions (ADR) in a pilot study of at-risk patients using state-of-the-art pharmacogenomic technology and to use this information to make recommendations for optimization of pharmacotherapy regimens. The data from the pilot cohort will be used to optimize and integrate a customized electronic decision support (clin…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * People taking 5 or more medications, including over the counter drugs, supplements, natural products, cannabis produces, or other recreational drugs * Ability to give and comprehend the consent process. * Consent to donate urine samples, genetic data through buccal swabs, unde…
Contacts

Kenneth S Ramos, MD

7136777740

kramos@tamu.edu

CONTACT